Compared to the parental SARS-CoV-2 virus, infections by the now dominant Delta variant of SARS-CoV-2 appear to be more common and more severe in pregnant women. The need for a robust, cheap, and quick method for diagnosing placental infection by SARS-CoV-2 has thus become more acute. Here, we describe a highly sensitive and specific immunohistochemical assay for SARS-CoV-2 nucleocapsid protein for routine use in placental pathology practice.
ItoKPianthamCNishiuraH. Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021. Euro Surveill. Jul 2021;26(27):2100570. doi:10.2807/1560-7917.ES.2021.26.27.2100570
2.
MishraSMindermannSSharmaM, et al.Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England. EClinicalMedicine. Sep 2021;39:101064. doi:10.1016/j.eclinm.2021.101064
3.
ThangarajJWVYadavPKumarCG, et al.Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021. J Infect. Aug 6 2021. doi:10.1016/j.jinf.2021.08.006
4.
AdhikariEHSoRelleJAMcIntireDDSpongCY. Increasing severity of COVID-19 in pregnancy with Delta (B.1.617.2) variant surge. Am J Obstet Gynecol. Sep 14 2021. doi:10.1016/j.ajog.2021.09.008
5.
VousdenNRamakrishnanRBunchK, et al.Impact of SARS-CoV-2 variant on the severity of maternal infection and perinatal outcomes: data from the UK obstetric surveillance system national cohort. medRxiv. 2021. doi:10.1101/2021.07.22.21261000
6.
SismanJJaleelMAMorenoW, et al.Intrauterine transmission of SARS-COV-2 infection in a preterm infant. Pediatr Infect Dis J. Sep 2020;39(9):e265-e267. doi:10.1097/INF.0000000000002815
7.
SchwartzDABaldewijnsMBenachiA, et al.Chronic histiocytic intervillositis with trophoblast necrosis is a risk factor associated with placental infection from coronavirus disease 2019 (COVID-19) and intrauterine maternal-fetal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in live-born and stillborn infants. Arch Pathol Lab Med. May 1 2021;145(5):517-528. doi:10.5858/arpa.2020-0771-SA
8.
BouachbaAAlliasFNadaudB, et al.Placental lesions and SARS-Cov-2 infection: diffuse placenta damage associated to poor fetal outcome. Placenta. Sep 1 2021;112:97-104. doi:10.1016/j.placenta.2021.07.288
9.
HusenMFvan der MeerenLEVerdijkRM, et al.Unique severe COVID-19 placental signature independent of severity of clinical maternal symptoms. Viruses. Aug 23 2021;13(8):1670. doi:10.3390/v13081670
10.
RobertsDJEdlowAGRomeroRJ, et al.A standardized definition of placental infection by SARS-CoV-2, a consensus statement from the National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development SARS-CoV-2 placental infection workshop. Am J Obstet Gynecol. Dec 2021;225(6):593 e1-593 e9. doi:10.1016/j.ajog.2021.07.029
11.
BartonLMDuvalEJStrobergEGhoshSMukhopadhyayS. COVID-19 autopsies, Oklahoma, USA. Am J Clin Pathol. May 5 2020;153(6):725-733. doi:10.1093/ajcp/aqaa062
12.
WatkinsJCTorousVFRobertsDJ. Defining severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) placentitis. Arch Pathol Lab Med. Nov 1 2021;145(11):1341-1349. doi:10.5858/arpa.2021-0246-SA
